HOME >> MEDICINE >> NEWS
Paclitaxel chemotherapy for breast cancer not associated with serious radiation pneumonitis

Breast cancer patients treated with paclitaxel-based chemotherapy and radiation therapy do not experience pneumonitis--an inflammation of lung tissue--more often than patients treated with radiation and a chemotherapy regimen that did not include paclitaxel, according to a new study that appears in the November 17 issue of the Journal of the National Cancer Institute.

The use of taxanes, such as paclitaxel, has led to improved outcomes for patients with metastatic breast cancer and for patients whose disease has spread to the lymph nodes. Radiation therapy is also an important adjuvant treatment to prevent local recurrence of breast cancer, but some of the radiation focused on the breast tissue and chest wall passes through the lungs. Although the resulting incidence of radiation pneumonitis is low with the use of modern irradiation techniques, some reports have suggested that this side effect occurs more often in patients who receive taxanes. However, only small, uncontrolled studies have investigated the effect of taxanes on the development of radiation pneumonitis.

To evaluate the association between paclitaxel chemotherapy and radiation pneumonitis, Thomas A. Buchholz, M.D., and Tse-Kuan Yu, M.D., Ph.D. of the University of Texas M. D. Anderson Cancer Center in Houston, and colleagues studied 189 breast cancer patients from a phase III randomized trial. The patients had been treated with either four cycles of paclitaxel followed by four cycles of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) and then radiation therapy or with eight cycles of FAC followed by radiation.

There was no difference in the rate of radiation pneumonitis between the two groups--5.0% in the paclitaxelFAC group versus 4.5% in the FAC group--and no patients were hospitalized for or died from the side effect in either group. The authors conclude that patients treated with paclitaxel-based chemotherapy do not have an increased risk of clinically releva
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
16-Nov-2004


Page: 1 2

Related medicine news :

1. Paclitaxel combination improves survival from small-cell lung cancer
2. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
3. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
4. MRI better than current standard in assessing neoadjuvant chemotherapy for breast cancer
5. Older women can benefit from chemotherapy to treat breast cancer
6. Resistance to chemotherapy
7. New treatment rivals chemotherapy for lymphoma, U-M study finds
8. Adding radiation therapy to chemotherapy improves survival in patients with high-risk breast cancer
9. Poor response to chemotherapy does not mean poor outcome for patients with rare breast cancer
10. Stanford study finds new method improves chemotherapy survival in mice
11. Study suggests Akt3 protein is key to melanomas resistance to chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... TAMPA, Fla. (PRWEB) , ... July 01, 2020 ... ... biotechnology LLC specializing in the clinical development of psychedelics and analogues, announces its ... years combined experience in natural product drug discovery, novel formulations, and as distinguished ...
(Date:6/28/2020)... ... , ... Medisend College of Biomedical Engineering Technology, a Dallas-based ... prepares graduates for professional careers as field service engineers and biomedical equipment technicians, ... Ms. Williams currently serves as Associate Vice Chancellor of Workforce and Community Initiatives ...
(Date:6/28/2020)... ... ... The secret of surviving a pandemic with one’s sanity intact does not lie ... the first product to disappear off the shelves when the COVID-19 crisis began. The ... need to venture out, the longer you can “survive”. However, does all this doomsday-like ...
(Date:6/25/2020)... ... ... Denials Management, Inc. has just published The Health Insurance Appeals Guide to ... of mental health and substance use disorder (MH/SUD) treatment services. It was written by ... the steps in the appeals process. Complimentary copies of the Guide can be ...
(Date:6/24/2020)... ... June 24, 2020 , ... ... announced that Wexford Physician Hospital Organization (PHO) has successfully deployed SPH’s Population Care™ ... the framework of value-based care. Use of Population Care is benefitting more than ...
Breaking Medicine News(10 mins):
(Date:7/7/2020)... ... July 07, 2020 , ... Halifax-based startup, Cribcut, has ... hair service provider. Now called Bright, the company has launched a workplace well-being ... beauty amenities as well as an array of well-being services that can be ...
(Date:7/4/2020)... ... July 03, 2020 , ... By Heidi Jean Doerfert , ... into our homes for cover, Assuaged, Inc. is going full speed ahead. ... the globe this year to get their feet wet in marketing, social media content, ...
(Date:7/2/2020)... ... 2020 , ... Exercise.com, the fitness industry’s leading tech company specializing in all-in-one ... through its software during the months of May and June. This announcement highlights the ... where even gym giants like 24 Hour Fitness and Gold’s Gym ...
Breaking Medicine Technology:
Cached News: